Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.53 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.53 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.53 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.53 |
| ▸ | NPC1 | O15118 | 3/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.53 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.53 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.53 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.53 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.53 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.53 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NAMPT | P43490 | 1/20 | 0.51 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1663183 | 0.91 | POLB (0.57) | POLBMAPK1ALDH1A1HDAC1HDAC2 | |
| SCHEMBL10363539 | 0.90 | MAPK1 (0.72) | POLBMAPK1ALDH1A1HDAC1HDAC2 | |
| SCHEMBL29833827 | 0.90 | POLB (0.74) | POLBMAPK1ALDH1A1HDAC1HDAC2 | |
| SCHEMBL1039449 | 0.87 | HDAC1 (0.69) | POLBMAPK1HDAC1HDAC2HDAC8 | |
| SCHEMBL23471096 | 0.86 | POLB (0.58) | POLBMAPK1ALDH1A1HDAC2HDAC8 | |
| SCHEMBL9717433 | 0.86 | POLB (0.68) | POLBMAPK1ALDH1A1NPC1RAB9A | |
| SCHEMBL9321669 | 0.85 | HDAC1 (0.72) | POLBMAPK1ALDH1A1HDAC1HDAC2 | |
| SCHEMBL7906054 | 0.85 | HDAC1 (0.72) | POLBMAPK1ALDH1A1HDAC1HDAC2 | |
| SCHEMBL2975968 | 0.84 | DRD2 (0.68) | POLBMAPK1HDAC1HDAC2HDAC8 | |
| SCHEMBL7393206 | 0.84 | POLB (0.66) | POLBMAPK1HDAC1HDAC6NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160376589-A1 | micro-RNA INHIBITOR | BONAC CORPORATION (JP) | 2016-12-29 | — | — | US | disclosed |
| US-9404108-B2 | Micro-RMA inhibitor | BONAC CORPORATION (JP) | 2016-08-02 | — | — | US | disclosed |
| US-20150073124-A1 | micro-RNA INHIBITOR | BONAC CORPORATION (JP) | 2015-03-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150073124-A1 | micro-RNA INHIBITOR | AGO2, SLIRP, MSI2 | POLB 922/4885MAPK1 1681/4885ALDH1A1 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.